CLINICAL_TRIALS
trial_result
· 2024-08-28
Clinical Trial Update: Effects of Tolcapone on Frontotemporal Dementia [Phase 2]
Summary
Phase 2 trial evaluating tolcapone for Frontotemporal dementia has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Columbia University | Conditions: Frontotemporal Lobar Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2024-08-28